- TWD216.94m
- TWD878.08m
- TWD804.03m
- 15
- 54
- 25
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,564 | 1,076 | 1,070 | 1,011 | 804 |
Cost of Revenue | |||||
Gross Profit | 196 | 183 | 242 | 260 | 209 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,719 | 1,129 | 1,063 | 990 | 826 |
Operating Profit | -155 | -53.5 | 7.23 | 20.7 | -21.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -112 | -32.5 | 23.2 | 41.1 | -14.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -116 | -34.7 | 18 | 32.6 | -20.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -115 | -39.7 | 5.27 | 9.38 | -36.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -115 | -39.7 | 5.27 | 9.38 | -36.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -8.16 | -2.8 | 0.375 | 0.66 | -2.6 |
Dividends per Share |